Click for best price
Therapeutic Recombinant Protein Market Size, Share 2024
The global Therapeutic Recombinant Protein market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Hormones Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Recombinant Protein include Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems and Abnova, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Recombinant Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Recombinant Protein. This report contains market size and forecasts of Therapeutic Recombinant Protein in global, including the following market information:
Global Therapeutic Recombinant Protein Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Therapeutic Recombinant Protein companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Recombinant Protein Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, by Type, 2023 (%)
Hormones
Blood Clotting Factors
Cytokines
Enzymes
Fusion Proteins
Others
Global Therapeutic Recombinant Protein Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, by Application, 2023 (%)
Pharmaceutical Company
Research Institute
Others
Global Therapeutic Recombinant Protein Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Therapeutic Recombinant Protein Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Recombinant Protein revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Therapeutic Recombinant Protein revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Recombinant Protein, market overview.
Chapter 2: Global Therapeutic Recombinant Protein market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Recombinant Protein company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Recombinant Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Therapeutic Recombinant Protein Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Recombinant Protein Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Recombinant Protein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Recombinant Protein Overall Market Size
2.1 Global Therapeutic Recombinant Protein Market Size: 2023 VS 2030
2.2 Global Therapeutic Recombinant Protein Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Therapeutic Recombinant Protein Players in Global Market
3.2 Top Global Therapeutic Recombinant Protein Companies Ranked by Revenue
3.3 Global Therapeutic Recombinant Protein Revenue by Companies
3.4 Top 3 and Top 5 Therapeutic Recombinant Protein Companies in Global Market, by Revenue in 2023
3.5 Global Companies Therapeutic Recombinant Protein Product Type
3.6 Tier 1, Tier 2 and Tier 3 Therapeutic Recombinant Protein Players in Global Market
3.6.1 List of Global Tier 1 Therapeutic Recombinant Protein Companies
3.6.2 List of Global Tier 2 and Tier 3 Therapeutic Recombinant Protein Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Recombinant Protein Market Size Markets, 2023 & 2030
4.1.2 Hormones
4.1.3 Blood Clotting Factors
4.1.4 Cytokines
4.1.5 Enzymes
4.1.6 Fusion Proteins
4.1.7 Others
4.2 By Type - Global Therapeutic Recombinant Protein Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Recombinant Protein Revenue, 2019-2024
4.2.2 By Type - Global Therapeutic Recombinant Protein Revenue, 2025-2030
4.2.3 By Type - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Recombinant Protein Market Size, 2023 & 2030
5.1.2 Pharmaceutical Company
5.1.3 Research Institute
5.1.4 Others
5.2 By Application - Global Therapeutic Recombinant Protein Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Recombinant Protein Revenue, 2019-2024
5.2.2 By Application - Global Therapeutic Recombinant Protein Revenue, 2025-2030
5.2.3 By Application - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Therapeutic Recombinant Protein Market Size, 2023 & 2030
6.2 By Region - Global Therapeutic Recombinant Protein Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Recombinant Protein Revenue, 2019-2024
6.2.2 By Region - Global Therapeutic Recombinant Protein Revenue, 2025-2030
6.2.3 By Region - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Therapeutic Recombinant Protein Revenue, 2019-2030
6.3.2 US Therapeutic Recombinant Protein Market Size, 2019-2030
6.3.3 Canada Therapeutic Recombinant Protein Market Size, 2019-2030
6.3.4 Mexico Therapeutic Recombinant Protein Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Therapeutic Recombinant Protein Revenue, 2019-2030
6.4.2 Germany Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.3 France Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.4 U.K. Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.5 Italy Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.6 Russia Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.7 Nordic Countries Therapeutic Recombinant Protein Market Size, 2019-2030
6.4.8 Benelux Therapeutic Recombinant Protein Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Therapeutic Recombinant Protein Revenue, 2019-2030
6.5.2 China Therapeutic Recombinant Protein Market Size, 2019-2030
6.5.3 Japan Therapeutic Recombinant Protein Market Size, 2019-2030
6.5.4 South Korea Therapeutic Recombinant Protein Market Size, 2019-2030
6.5.5 Southeast Asia Therapeutic Recombinant Protein Market Size, 2019-2030
6.5.6 India Therapeutic Recombinant Protein Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Therapeutic Recombinant Protein Revenue, 2019-2030
6.6.2 Brazil Therapeutic Recombinant Protein Market Size, 2019-2030
6.6.3 Argentina Therapeutic Recombinant Protein Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Therapeutic Recombinant Protein Revenue, 2019-2030
6.7.2 Turkey Therapeutic Recombinant Protein Market Size, 2019-2030
6.7.3 Israel Therapeutic Recombinant Protein Market Size, 2019-2030
6.7.4 Saudi Arabia Therapeutic Recombinant Protein Market Size, 2019-2030
6.7.5 UAE Therapeutic Recombinant Protein Market Size, 2019-2030
7 Therapeutic Recombinant Protein Companies Profiles
7.1 Abcam
7.1.1 Abcam Company Summary
7.1.2 Abcam Business Overview
7.1.3 Abcam Therapeutic Recombinant Protein Major Product Offerings
7.1.4 Abcam Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.1.5 Abcam Key News & Latest Developments
7.2 HALIX
7.2.1 HALIX Company Summary
7.2.2 HALIX Business Overview
7.2.3 HALIX Therapeutic Recombinant Protein Major Product Offerings
7.2.4 HALIX Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.2.5 HALIX Key News & Latest Developments
7.3 Avantor
7.3.1 Avantor Company Summary
7.3.2 Avantor Business Overview
7.3.3 Avantor Therapeutic Recombinant Protein Major Product Offerings
7.3.4 Avantor Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.3.5 Avantor Key News & Latest Developments
7.4 Miltenyi Biotec
7.4.1 Miltenyi Biotec Company Summary
7.4.2 Miltenyi Biotec Business Overview
7.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Major Product Offerings
7.4.4 Miltenyi Biotec Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.4.5 Miltenyi Biotec Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Major Product Offerings
7.5.4 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Bio-Techne Corporation
7.6.1 Bio-Techne Corporation Company Summary
7.6.2 Bio-Techne Corporation Business Overview
7.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Major Product Offerings
7.6.4 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.6.5 Bio-Techne Corporation Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Therapeutic Recombinant Protein Major Product Offerings
7.7.4 Merck Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 ACROBiosystems
7.8.1 ACROBiosystems Company Summary
7.8.2 ACROBiosystems Business Overview
7.8.3 ACROBiosystems Therapeutic Recombinant Protein Major Product Offerings
7.8.4 ACROBiosystems Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.8.5 ACROBiosystems Key News & Latest Developments
7.9 Abnova
7.9.1 Abnova Company Summary
7.9.2 Abnova Business Overview
7.9.3 Abnova Therapeutic Recombinant Protein Major Product Offerings
7.9.4 Abnova Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.9.5 Abnova Key News & Latest Developments
7.10 Eurogentec (Kaneka Corporation)
7.10.1 Eurogentec (Kaneka Corporation) Company Summary
7.10.2 Eurogentec (Kaneka Corporation) Business Overview
7.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Major Product Offerings
7.10.4 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.10.5 Eurogentec (Kaneka Corporation) Key News & Latest Developments
7.11 Cytiva (Danaher )
7.11.1 Cytiva (Danaher ) Company Summary
7.11.2 Cytiva (Danaher ) Business Overview
7.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Major Product Offerings
7.11.4 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.11.5 Cytiva (Danaher ) Key News & Latest Developments
7.12 Reprocell
7.12.1 Reprocell Company Summary
7.12.2 Reprocell Business Overview
7.12.3 Reprocell Therapeutic Recombinant Protein Major Product Offerings
7.12.4 Reprocell Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.12.5 Reprocell Key News & Latest Developments
7.13 GenScript
7.13.1 GenScript Company Summary
7.13.2 GenScript Business Overview
7.13.3 GenScript Therapeutic Recombinant Protein Major Product Offerings
7.13.4 GenScript Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.13.5 GenScript Key News & Latest Developments
7.14 BPS Bioscience
7.14.1 BPS Bioscience Company Summary
7.14.2 BPS Bioscience Business Overview
7.14.3 BPS Bioscience Therapeutic Recombinant Protein Major Product Offerings
7.14.4 BPS Bioscience Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.14.5 BPS Bioscience Key News & Latest Developments
7.15 Sino Biological
7.15.1 Sino Biological Company Summary
7.15.2 Sino Biological Business Overview
7.15.3 Sino Biological Therapeutic Recombinant Protein Major Product Offerings
7.15.4 Sino Biological Therapeutic Recombinant Protein Revenue in Global Market (2019-2024)
7.15.5 Sino Biological Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Therapeutic Recombinant Protein Market Opportunities & Trends in Global Market
Table 2. Therapeutic Recombinant Protein Market Drivers in Global Market
Table 3. Therapeutic Recombinant Protein Market Restraints in Global Market
Table 4. Key Players of Therapeutic Recombinant Protein in Global Market
Table 5. Top Therapeutic Recombinant Protein Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Therapeutic Recombinant Protein Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Therapeutic Recombinant Protein Revenue Share by Companies, 2019-2024
Table 8. Global Companies Therapeutic Recombinant Protein Product Type
Table 9. List of Global Tier 1 Therapeutic Recombinant Protein Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Recombinant Protein Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Therapeutic Recombinant Protein Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Therapeutic Recombinant Protein Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Therapeutic Recombinant Protein Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Therapeutic Recombinant Protein Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Therapeutic Recombinant Protein Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Therapeutic Recombinant Protein Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Therapeutic Recombinant Protein Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Therapeutic Recombinant Protein Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Therapeutic Recombinant Protein Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Therapeutic Recombinant Protein Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Therapeutic Recombinant Protein Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Therapeutic Recombinant Protein Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Therapeutic Recombinant Protein Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Therapeutic Recombinant Protein Revenue, (US$, Mn), 2025-2030
Table 30. Abcam Company Summary
Table 31. Abcam Therapeutic Recombinant Protein Product Offerings
Table 32. Abcam Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 33. Abcam Key News & Latest Developments
Table 34. HALIX Company Summary
Table 35. HALIX Therapeutic Recombinant Protein Product Offerings
Table 36. HALIX Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 37. HALIX Key News & Latest Developments
Table 38. Avantor Company Summary
Table 39. Avantor Therapeutic Recombinant Protein Product Offerings
Table 40. Avantor Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 41. Avantor Key News & Latest Developments
Table 42. Miltenyi Biotec Company Summary
Table 43. Miltenyi Biotec Therapeutic Recombinant Protein Product Offerings
Table 44. Miltenyi Biotec Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 45. Miltenyi Biotec Key News & Latest Developments
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific Therapeutic Recombinant Protein Product Offerings
Table 48. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Bio-Techne Corporation Company Summary
Table 51. Bio-Techne Corporation Therapeutic Recombinant Protein Product Offerings
Table 52. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 53. Bio-Techne Corporation Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Therapeutic Recombinant Protein Product Offerings
Table 56. Merck Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 57. Merck Key News & Latest Developments
Table 58. ACROBiosystems Company Summary
Table 59. ACROBiosystems Therapeutic Recombinant Protein Product Offerings
Table 60. ACROBiosystems Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 61. ACROBiosystems Key News & Latest Developments
Table 62. Abnova Company Summary
Table 63. Abnova Therapeutic Recombinant Protein Product Offerings
Table 64. Abnova Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 65. Abnova Key News & Latest Developments
Table 66. Eurogentec (Kaneka Corporation) Company Summary
Table 67. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product Offerings
Table 68. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 69. Eurogentec (Kaneka Corporation) Key News & Latest Developments
Table 70. Cytiva (Danaher ) Company Summary
Table 71. Cytiva (Danaher ) Therapeutic Recombinant Protein Product Offerings
Table 72. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 73. Cytiva (Danaher ) Key News & Latest Developments
Table 74. Reprocell Company Summary
Table 75. Reprocell Therapeutic Recombinant Protein Product Offerings
Table 76. Reprocell Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 77. Reprocell Key News & Latest Developments
Table 78. GenScript Company Summary
Table 79. GenScript Therapeutic Recombinant Protein Product Offerings
Table 80. GenScript Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 81. GenScript Key News & Latest Developments
Table 82. BPS Bioscience Company Summary
Table 83. BPS Bioscience Therapeutic Recombinant Protein Product Offerings
Table 84. BPS Bioscience Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 85. BPS Bioscience Key News & Latest Developments
Table 86. Sino Biological Company Summary
Table 87. Sino Biological Therapeutic Recombinant Protein Product Offerings
Table 88. Sino Biological Therapeutic Recombinant Protein Revenue (US$, Mn) & (2019-2024)
Table 89. Sino Biological Key News & Latest Developments
List of Figures
Figure 1. Therapeutic Recombinant Protein Segment by Type in 2023
Figure 2. Therapeutic Recombinant Protein Segment by Application in 2023
Figure 3. Global Therapeutic Recombinant Protein Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Therapeutic Recombinant Protein Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Therapeutic Recombinant Protein Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Therapeutic Recombinant Protein Revenue in 2023
Figure 8. By Type - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 9. By Application - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 10. By Type - Global Therapeutic Recombinant Protein Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 12. By Application - Global Therapeutic Recombinant Protein Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 14. By Region - Global Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 15. By Country - North America Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 16. US Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 20. Germany Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 21. France Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 28. China Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 32. India Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 34. Brazil Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Therapeutic Recombinant Protein Revenue Market Share, 2019-2030
Figure 37. Turkey Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Therapeutic Recombinant Protein Revenue, (US$, Mn), 2019-2030
Figure 41. Abcam Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. HALIX Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Avantor Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Miltenyi Biotec Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Merck Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. ACROBiosystems Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Abnova Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Reprocell Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. GenScript Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. BPS Bioscience Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Sino Biological Therapeutic Recombinant Protein Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
